213 related articles for article (PubMed ID: 22079685)
21. Lp(a), oxidized phospholipids and oxidation-specific epitopes are increased in subjects with keloid formation.
Ruder S; Mansfield B; Immelman AR; Varki N; Miu P; Raal F; Tsimikas S
Lipids Health Dis; 2022 Nov; 21(1):113. PubMed ID: 36320028
[TBL] [Abstract][Full Text] [Related]
22. Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.
Nsaibia MJ; Mahmut A; Boulanger MC; Arsenault BJ; Bouchareb R; Simard S; Witztum JL; Clavel MA; Pibarot P; Bossé Y; Tsimikas S; Mathieu P
J Intern Med; 2016 Nov; 280(5):509-517. PubMed ID: 27237700
[TBL] [Abstract][Full Text] [Related]
23. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).
Tsimikas S; Duff GW; Berger PB; Rogus J; Huttner K; Clopton P; Brilakis E; Kornman KS; Witztum JL
J Am Coll Cardiol; 2014 May; 63(17):1724-34. PubMed ID: 24530664
[TBL] [Abstract][Full Text] [Related]
24. Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina.
Segev A; Strauss BH; Witztum JL; Lau HK; Tsimikas S
Am Heart J; 2005 Nov; 150(5):1007-14. PubMed ID: 16290986
[TBL] [Abstract][Full Text] [Related]
25. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
Capoulade R; Chan KL; Yeang C; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Mahmut A; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
J Am Coll Cardiol; 2015 Sep; 66(11):1236-1246. PubMed ID: 26361154
[TBL] [Abstract][Full Text] [Related]
26. Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.
Kamstrup PR; Hung MY; Witztum JL; Tsimikas S; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1570-1578. PubMed ID: 28572160
[TBL] [Abstract][Full Text] [Related]
27. Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes.
Gilliland TC; Liu Y; Mohebi R; Miksenas H; Haidermota S; Wong M; Hu X; Cristino JR; Browne A; Plutzky J; Tsimikas S; Januzzi JL; Natarajan P
J Am Coll Cardiol; 2023 May; 81(18):1780-1792. PubMed ID: 37137588
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
Zheng KH; Tsimikas S; Pawade T; Kroon J; Jenkins WSA; Doris MK; White AC; Timmers NKLM; Hjortnaes J; Rogers MA; Aikawa E; Arsenault BJ; Witztum JL; Newby DE; Koschinsky ML; Fayad ZA; Stroes ESG; Boekholdt SM; Dweck MR
J Am Coll Cardiol; 2019 May; 73(17):2150-2162. PubMed ID: 31047003
[TBL] [Abstract][Full Text] [Related]
29. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
[TBL] [Abstract][Full Text] [Related]
30. Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack.
Byun YS; Yang X; Bao W; DeMicco D; Laskey R; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2017 Jan; 69(2):147-158. PubMed ID: 28081824
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous coronary intervention for multiple chronic total occlusions.
Danzi GB; Valenti R; Migliorini A; Parodi G; Vergara R; Antoniucci D
Am J Cardiol; 2013 Dec; 112(12):1849-53. PubMed ID: 24063833
[TBL] [Abstract][Full Text] [Related]
32. Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial.
Budoff MJ; Ahmadi N; Gul KM; Liu ST; Flores FR; Tiano J; Takasu J; Miller E; Tsimikas S
Prev Med; 2009; 49(2-3):101-7. PubMed ID: 19573556
[TBL] [Abstract][Full Text] [Related]
33. Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trial.
Byun YS; Lee JH; Arsenault BJ; Yang X; Bao W; DeMicco D; Laskey R; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2015 Apr; 65(13):1286-1295. PubMed ID: 25835440
[TBL] [Abstract][Full Text] [Related]
34. Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.
Tsimikas S; Aikawa M; Miller FJ; Miller ER; Torzewski M; Lentz SR; Bergmark C; Heistad DD; Libby P; Witztum JL
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):175-81. PubMed ID: 17082490
[TBL] [Abstract][Full Text] [Related]
35. Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events.
Prasad A; Clopton P; Ayers C; Khera A; de Lemos JA; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1213-1221. PubMed ID: 28473443
[TBL] [Abstract][Full Text] [Related]
36. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial.
Capoulade R; Chan KL; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
Atherosclerosis; 2017 May; 260():1-7. PubMed ID: 28319871
[TBL] [Abstract][Full Text] [Related]
38. Effect of bariatric surgery on plasma levels of oxidised phospholipids, biomarkers of oxidised LDL and lipoprotein(a).
Ho JH; Adam S; Liu Y; Azmi S; Dhage S; Syed AA; Ammori BJ; Donn R; Heald A; Gibson MJ; Malik RA; Yang X; Durrington PN; Tsimikas S; Soran H
J Clin Lipidol; 2021; 15(2):320-331. PubMed ID: 33518459
[TBL] [Abstract][Full Text] [Related]
39. Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.
Clarke R; Hammami I; Sherliker P; Valdes-Marquez E; Watkins H; Hill M; Yang X; Tsimikas S; Hopewell JC;
Atherosclerosis; 2022 Aug; 354():15-22. PubMed ID: 35803063
[TBL] [Abstract][Full Text] [Related]
40. Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.
Capoulade R; Yeang C; Chan KL; Pibarot P; Tsimikas S
JAMA Cardiol; 2018 Dec; 3(12):1212-1217. PubMed ID: 30476957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
